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An enantioselective route to cis-perhydroisoquinolines, involving a cyclocondensation reaction of (R)-phenylglycinol 
with a racemic oxoester, a stereoselective conjugate addition to an unsaturated bicyclic lactam, and the closure of 
the carbocyclic ring by a ring-closing metathesis as the key steps is reported. This route allows the preparation of 3-
cyano derivatives as well as cis-octahydroisoquinolines bearing a quaternary center at the C4-position. 
The totally (or partially) reduced cis-isoquinoline ring 
system is present in a large number of bioactive natural 
and synthetic products.  Among them, of particular 
interest are the indole alkaloids of the yohimbine-
reserpine type,
1
 the marine sponge alkaloids of the 
manzamine
2
 and madangamine groups,
3
 all of them 
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displaying a variety of notable pharmacological activities, 
and the HIV protease inhibitors nelfinavir and 
saquinavir,
4
 which are characterized by the presence of a 
carboxamide function at the C3-position of the 
isoquinoline ring
5
    (Figure  1).   This    widespread    
occurrence    has 
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Figure 1. Compounds Bearing a cis-Perhydroisoquinoline 
                 Moiety. 
                                                   
 
 
stimulated the development of general methodologies and 
strategies for the enantioselective synthesis of cis-
perhydroisoquinoline derivatives.
6
 In this context, we 
have recently reported
7
 an enantiodivergent synthesis of 
cis-hydroisoquinolines, in which the key step was a 
diastereoselective Diels-Alder reaction of a 
phenylglycinol-derived unsaturated δ-lactam.  
 
Scheme 1. Enantioselective Synthesis of cis- 
                  Perhydroisoquinolin-3-one 
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We present here an efficient enantioselective route to 
cis-perhydroisoquinolines. The key steps are i) the 
generation of the first enantiopure intermediate, the 
bicyclic lactam 2, by cyclocondensation of (R)-
phenylglycinol with racemic γ-substituted δ-oxoester 1, in 
a process that involves a dynamic kinetic resolution; ii) a 
highly stereoselective conjugate addition to unsaturated 
lactam 3; iii) the closure of the carbocyclic ring by a ring-
closing olefin metathesis (RCM).  
The starting racemic oxoester 1 was conveniently 
prepared in 64% yield by reaction of the piperidine 
enamine of 4-pentenal with methyl acrylate.
8
 
Cyclocondensation of 1 with (R)-phenylglycinol at 0 ºC in 
the presence of anhydrous Na2SO4, followed by heating at 
75-80 ºC under vacuum  (10-15 mmHg) stereoselectively 
afforded the enantiopure bicyclic lactam 2 in 71% yield 
(Scheme 1). Minor amounts (10%) of the (8S,8aS)-
diastereoisomer were also isolated. The above result 
clearly indicated that a dynamic kinetic resolution,
9
 with 
epimerization of the configurationally labile stereocenter 
α to the carbonyl group, had occurred during the 
cyclocondensation reaction.  
Lactam 2 was then converted to the unsaturated lactams 
3 by sequential treatment with LHMDS (2.2 equiv), 
methyl or benzyl chloroformate, and PhSeCl, followed by 
oxidation of the resulting mixtures of selenides with H2O2 
in the presence of pyridine. Lactams 3 proved to be 
sensitive to both mild acid and basic conditions, affording 
the corresponding pyridones 9. For this reason, they were 
prepared immediately before the next reaction and used 
without further purification.  
The conjugate addition of an allyl group was 
accomplished in excellent chemical yield and complete 
exo facial diastereoselectivity
10
 by reacting lactams 3a 
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and 3b with allylmagnesium bromide in presence of CuI, 
LiCl, and TMSCl. The observed stereoselectivity can be 
explained by considering that the attack of the nucleophile 
takes place, under stereoelectronic control, axial to the 
electrophilic carbon of the conjugated double bond of the 
conformationally rigid lactams 3, and consequently cis 
with respect to the allyl substituent, as depicted in Figure 
2. 
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Figure 2.  Stereoelectronic Control in the Conjugate Addition. 
 
The resulting cis-diallyl lactams 4a and 4b were 
isolated as mixtures of epimers at the isomerizable 
stereocenter adjacent to the ester and lactam carbonyl 
groups (approximate ratio of CO2R α:β isomers, 4:1 for 
4a and 3:1 for 4b), which could be separated by column 
chromatography. 
The RCM
11
 of lactams 4a and 4b catalyzed by the 
second generation Grubbs catalyst 10a resulted in the 
closure of the carbocyclic ring to give the respective 
hydroisoquinolones 5a and 5b in excellent yield. When 
the RCM from 4a was carried out using the first 
generation Grubbs catalyst 10b (7.5% mol), cyclization 
was slower and hydroisoquinolone 5a was isolated in only 
66% yield after 20 h.  
Catalytic hydrogenation of 5a using Pd/C as the 
catalyst brought about both the reduction of the carbon-
carbon double bond and the debenzylation of the 
benzyloxycarbonyl group to give a β-keto acid, which was 
then decarboxylated by heating in refluxing toluene, 
leading to a single perhydroisoquinolone 6 in 85% overall 
yield.  
Removal of the chiral auxiliary was performed in two 
steps, by reduction with triethylsilane in the presence of 
TiCl4, followed by debenzylation of the resulting 2-
piperidone 7 with Na in liquid NH3. The enantiopure cis-
perhydroisoquinolin-3-one 8 [[α]22D – 29.2 (c 0.8, 
MeOH); lit
12a
 [α]22D –30.9 (c 1.02, MeOH)] was obtained 
in excellent overall yield. Bicyclic lactam 8 has 
previously been used as an advanced intermediate in the 
synthesis of (–)-alloyohimbane.
6b,12
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Alternatively, alane reduction of 6, followed by 
debenzylation of the resulting tertiary amine 11 by 
hydrogenation in the presence of Pd(OH)2 and (Boc)2O 
gave the enantiopure N-protected cis-
perhydroisoquinoline 12
13
 (Scheme 2).  
 
 
Scheme 2.  Synthesis of Enantiopure N-Protected cis- 
                   Perhydroisoquinoline 
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On the other hand, perhydroisoquinolone 8 provides 
easy access to derivatives bearing a cyano substituent at 
the C3-position. Thus, after protection of the nitrogen 
atom as an N-benzyloxycarbonyl carbamate, the carbonyl 
group of 13 was reduced under Speckamp conditions
14
 
and the resulting ethoxy derivative was treated with 
Me3SiCN in the presence of ZnCl2 to give 
perhydroisoquinoline-3-carbonitrile 14 in good overall 
yield (Scheme 3).  
The alkoxycarbonyl group present in 5b not only 
enhances the reactivity of the conjugated system, thus 
allowing the subsequent conjugate addition of an 
organocuprate, but also can later be manipulated to 
ultimately lead to octahydroisoquinolines bearing a 
quaternary center at the C4-position. 
 
 
Scheme 3. Enantioselective Access to cis-3- 
                   Cyanoperhydroisoquinolines 
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Thus, keto ester 5b underwent stereoselective 
alkylation on the most accessible face with complete 
facial selectivity by treatment with LHMDS and ethyl 
iodide, allyl bromide, 3-(tert-butyldimethylsilyloxy) 
propyl iodide, or 2-(2-iodoethyl)-1,3-dioxolane (Scheme 
4). LiAlH4 reduction of the alkylated compounds 15b-15d 
caused the cleavage of the C-O bond of the oxazolidine 
ring and the simultaneous reduction of the ester and amide 
carbonyl groups to give the respective alcohols 16b-16d 
in good yields. Functionalized cis-octahydroisoquinolines 
16, bearing the crucial quaternary center of 
madangamines, may allow an enantioselective entry to the 
tricyclic core of these alkaloids.
15
 
 
 
Scheme 4.  Towards the First Enantioselective Entry to the 
                   Tricyclic Core of Madangamine Alkaloids 
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 The results reported in this letter further illustrate that 
chiral non-racemic lactams generated by 
cyclocondensation reactions of 1,2-amino alcohols and δ-
oxoesters are versatile building blocks for the 
enantioselective synthesis of piperidine-containing 
derivatives.
16
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